Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/16/24 20:02 | 5/16/24 | XGN | Health | Health | Medical Laboratories | Aballi John | CA | DO | P,CEO | P | 78 | 1.92 | 0 | 40 | 7 | 641 | I | ||||||||||||||
6/20/23 17:04 | 6/15/23 | XGN | Health | Health | Medical Laboratories | Tullis James L L | FL | T | P | 1 | 3.11 | 0 | 0 | 0 | 1,543 | I | |||||||||||||||
12/9/22 09:00 | 12/8/22 | XGN | Health | Health | Medical Laboratories | Aballi John | CA | DO | P,CEO | P | 241 | 2.68 | 0 | 90 | 26 | 440 | D | ||||||||||||||
9/7/21 08:25 | 9/3/21 | XGN | Health | Health | Medical Laboratories | Johnson Wendy S. | CA | D | P | 14 | 14.02 | 0 | 1 | New | 1 | D | |||||||||||||||
9/23/19 21:43 | 9/23/19 | XGN | Health | Health | Medical Laboratories | H.I.G. Bio-Exagen, L.P. | FL | T | P.d | 5,950 | 14.00 | 0 | 425 | 33 | 1,696 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |